Facebook
Twitter
LinkedIn
Forward
Cytopathology and Small Biopsy Update - LIVESTREAM (VIRTUAL ONLY)
LIVESTREAM (virtual) attendance
Physicians and cytologists need the most up to date knowledge and strategies in pathology and cytopathology in order to provide the most appropriate ancillary testing for their patients and for guiding patient management. With the current update, attendees will learn the various new evidence-based reporting terminologies or updates to previously existing ones.. This will enable them to assess the patient’s risk of malignancy specifically regarding findings in thyroid, respiratory, urinary, body fluid, and pancreatobiliary cytology and small biopsies. By understanding these new site-specific reporting systems, attendees will know the risk of malignancy associated with each reporting category and appropriate ancillary testing; and therefore better guide management of their patients The World Health Organization under the guidance of the International Academy of Cytology and other organizations is currently in the process of publishing cytopathology reporting terminology. An update/status on these will be provided. Additionally, digital pathology and other new technologies, as they apply specifically to cytology and small specimens, will be discussed. New developments in the field that will impact patient care in the future will also be presented.
FEES
| REGISTRATION TYPE | FEE |
| Physician (Private physician, non-Houston Methodist) | $245 |
| Physician (Houston Methodist, HMPAQ member, or HMCC ACO PCP member) | $50 |
| Cytotechnologist | $75 |
| Resident / Fellow / Student | $75 |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.
Target Audience
Physicians, residents and fellows, cytopathologists, cytotechnologists, pathologists, residents and fellows in pathology, ENT, endocrinology, urology and internal medicine.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Describe the diagnosis molecular testing and management of thyroid nodules and update to the Thyroid Bethesda System Reporting Terminology.
- Understand how the risk of malignancy in reporting terminology is affected by the inclusion of non-invasive follicular thyroid neoplasm with papillary like features (NIFTP).
- Understand respiratory, pancreatobiliary, urinary and body fluid cytology reporting terminology, risk of malignancy associated with the various reporting categories, and new ancillary testing options
- Apply appropriate molecular testing to small specimens for management of lesions of lung, pancreaticobiliary, urinary tract and other systems
- Participants should be able to define risk stratification based on cytology and HPV testing in gynecologic cytology
- Be current on the role of HPV testing in head and neck cancer and Lower anogenital tract reporting terminology
| TIME | PRESENTATION | SPEAKER(S) |
| 7:15 AM | Registration and Breakfast | |
| 8:00 AM | Welcome | Dina R. Mody, MD |
| 8:05 AM | Overview of the Revised 3rd Edition Bethesda System for Reporting Thyroid Cytopathology | Paul A. VanderLaan, MD, PhD |
| 9:00 AM | Q & A Discussion | |
| 9:05 AM | WHO System for Reporting Pancreaticobiliary Cytology: An Overview | Momin T. Siddiqui, MD |
| 9:55 AM | Q & A Discussion | |
| 10:00 AM | BREAK AND POSTER REVIEW | |
| 10:30 AM | Paris 2.0: Highlights and Updates in Urinary Cytology | Momin T. Siddiqui, MD |
| 11:10 AM | Q & A Discussion | |
| 11:15 AM | Computational Cytology: Past, Present and Future | Michael W. Riben, MD |
| 11:55 AM | Q & A Discussion | |
| 12:00 PM | LUNCH | |
| 1:15 PM | Diagnostic and Ancillary Testing of Pulmonary Cytopathology and Small Biopsy Specimens | Paul A. VanderLaan, MD, PhD |
| 2:10 PM | Q & A Discussion | |
| 2:15 PM | HPV Testing in Gynecologic Cytology and Primary HPV Screening. Current Status and Future Directions | Michael J. Thrall, MD |
| 2:55 PM | Q & A Discussion | |
| 3:00 PM | BREAK AND POSTER REVIEW | |
| 3:30 PM | Update on HPV Testing in Head and Neck Cancer | Mary R. Schwartz, MD |
| 3:55 PM | Q & A Discussion | |
| 4:00 PM | Innovative Next Generation Cytology Imaging and Implications for our Practice | Savitri Krishnamurthy, MD |
| 4:25 PM | Q & A Discussion | |
| 4:30 PM | Update on Other Cytology Reporting Terminologies (Body fluids, Salivary, WHO on Musculoskeletal, Lymph nodes) | Elizabeth M. Jacobi, MD |
| 5:00 PM | Q & A Discussion | |
| 5:05 PM | Adjournment | |
| COURSE DIRECTORS |
| Dina R. Mody, MD |
| Ibrahim Ramzy Chair in Pathology Medical Director of Cytopathology Houston Methodist Dept of Pathology and Genomic Medicine Professor of Pathology and Laboratory Medicine |
| Mary Schwartz, MD |
| Jack L. Titus Chair in Pathology Medical Director, Anatomic Pathology Houston Methodist Dept. of Pathology and Genomic Medicine |
| GUEST FACULTY |
| Savitri Krishnamurthy, MD |
| Professor, Department of Pathology Division of Division of Pathology and Laboratory Medicine (term tenure) The University of Texas MD Anderson Cancer Center |
| Michael W. Riben, MD |
| Professor, Department of Pathology Division of Pathology/Lab Medicine Director of Anatomic Pathology Informatics The University of Texas MD Anderson Cancer Center |
| Momin T. Siddiqui, MD |
| Medical Director of the Papanicolaou Cytology Laboratory Professor, Department of Pathology Weill Cornell Medical College, NY |
| Paul A. VanderLaan, MD, PhD |
| Associate Professor, Pathology, Harvard Medical School Director of Surgical Pathology Director of Cytopathology Director of Thoracic Pathology Department of Pathology Beth Israel Deaconess Medical Center |
| HOUSTON METHODIST FACULTY |
| Elizabeth M. Jacobi, MD |
| Assistant Professor of Clinical Pathology and Genomic Medicine, Academic Institute Assistant Clinical Member, Research Institute Houston Methodist |
| Michael J. Thrall, MD |
| Professor of Pathology and Genomic Medicine, Academic Institute Full Clinical Member, Research Institute Program Director, Cytopathology Fellowship, Department of Pathology & Genomic Medicine Houston Methodist |
Available Credit
- 6.75 AMA PRA Category 1 Credit™
Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Houston Methodist designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 6.75 Attendance
- 6.75 CytotechnologistsThis course has been approved for up to 6.75 hours by the American Society for Cytopathology for Continuing Medical Laboratory Education (CMLE) for cytotechnologists.
Price
By registering for this activity you are agreeing to the Terms and Conditions.
STEPS TO REGISTER:
- STEP 1 - Choose the appropriate fee and click the "Add to Cart" button to complete the checkout process.
- STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.
FEES
| REGISTRATION TYPE | FEE |
| Physician (Private physician, non-Houston Methodist) | $245 |
| Physician (Houston Methodist, HMPAQ member, or HMCC ACO PCP member) | $50 |
| Cytotechnologist | $75 |
| Resident / Fellow / Student | $75 |
* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.